Compare Antibiotic

10 products »

close Created with Sketch.

Besivance

Bausch + Lomb Inc.

Besivance (besifloxacin ophthalmic suspension) 0.6% is a fluoroquinolone indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria: CDC coryneform group G Corynebacterium pseudodiphtheriticum* Corynebacterium striatum* Haemophilus influenzae Moraxella lacunata* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus hominis* Staphylococcus lugdunensis* Streptococcus mitis group Streptococcus oralis Streptococcus pneumoniae Streptococcus salivarius* *Efficacy for this organism was studied in fewer than 10 infections.

At-a-Glance
  • Mechanism of Action: Besifloxacin is an 8-chloro fluoroquinolone with a N-1 cyclopropyl group. The compound has activity against Gram-positive and Gram-negative bacteria due to the inhibition of both bacterial DNA gyrase and topoisomerase IV.
  • Dosage: One drop in the affected eye(s) 3 times a day, four to twelve hours apart for 7 days.

Details

FDA

Yes

CE Mark

Not specified

Active Ingredients

Besifloxacin

Application

Topical

Status

Prescription

Strength

0.6%

Company Information

Contact the company for additional information, availability, or pricing:

Bausch + Lomb Inc.

bausch.com

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807